National settlements with two generic drug companies over allegedly massive price-fixing conspiracies could be the first of several, and an increasing number of Oregonians may find themselves eligible for reimbursement.

Walgreens has agreed to pay $100 million to settle a proposed class action lawsuit accusing it of fraudulently overcharging customers for a decade when they bought generic drugs through private insurance,

Attorney General Keith Ellison celebrates settlements with two drug companies he accused of “scheming” to raise prices on generic medications.

The lawsuit, which was filed in 2017, alleged that Walgreens required insured customers to pay more than members of its Prescription Savings Club.

A coalition of state attorneys general, including those in Pennsylvania and New Jersey, has reached agreements with two prescription drug manufacturers settling claims that they participated in an industrywide scheme to inflate prices and restrain competition.

Walgreens (WBA) settles a deceptive pricing lawsuit, agreeing to a $100 million payment. Plaintiffs allege Walgreens inflated drug prices for insured customers.